A randomized controlled trial of acetyl salicylic acid in the secondary prevention of mortality from myocardial infarction
- PMID: 4593555
- PMCID: PMC1633246
- DOI: 10.1136/bmj.1.5905.436
A randomized controlled trial of acetyl salicylic acid in the secondary prevention of mortality from myocardial infarction
Abstract
The results of a randomized controlled trial of a single daily dose of acetyl salicylic acid (aspirin) in the prevention of reinfarction in 1,239 men who had had a recent myocardial infarct were statistically inconclusive. Nevertheless, they showed a reduction in total mortality of 12% at six months and 25% at twelve months after admission to the trial. Further trials are urgently required to establish whether or not this effect is real.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources